GlaxoSmithKline has announced that Dr Patrick Vallance, president, R&D, has informed the board of his intention to leave the company to become the UK Government's Chief Scientific Adviser and Head of the Government's Office for Science.
Original Article: GSK R&D president Patrick Vallance to become UK Government's chief scientific adviser
NEXT ARTICLE